E-LIB Suche - Ergebnisse für: Arteaga, Carlos L.

1

PRMT5 is an actionable therapeutic target in CDK4/6 inhibit..:

Lin, Chang-Ching ; Chang, Tsung-Cheng ; Wang, Yunguan...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

2

ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity a..:

Xu, Yaru ; Yang, Yuqiu ; Wang, Zhaoning...
Cancer Discovery. , 2024

Link: https://doi.org/10.1158/..

3

HER2 heterogeneity and treatment response–associated profil..:

Li, Zheqi ; Metzger Filho, Otto ; Viale, Giuseppe...
Journal of Clinical Investigation. 134 (2024) 7 - p. , 2024

Link: https://doi.org/10.1172/..

4

A randomized phase III double-blind placebo-controlled tria..:

Mezzanotte-Sharpe, Jessica ; ONeill, Anne ; Mayer, Ingrid A....
Breast Cancer Research and Treatment. , 2024

Link: https://doi.org/10.1007/..

5

Author Correction: Targeting LIPA independent of its lipase..:

Liu, Xihui ; Viswanadhapalli, Suryavathi ; Kumar, Shourya...
Nature Cancer. 5 (2024) 6 - p. 953-953 , 2024

Link: https://doi.org/10.1038/..

6

Adjuvant platinum versus capecitabine for residual, invasiv..:

Smith, Karen L. ; Zhao, Fengmin ; Mayer, Ingrid A....
Cancer. , 2024

Link: https://doi.org/10.1002/..

7

Solid waste management and urban environmental quality of p..:

Arteaga, Carlos ; Silva, Jhon ; Yarasca-Aybar, Cristian
City and Environment Interactions. 20 (2023) - p. 100112 , 2023

Link: https://doi.org/10.1016/..

8

Dendritic cell therapy augments antitumor immunity triggere..:

Kumar, Amrendra ; Ramani, Vijay ; Bharti, Vijaya...
Journal for ImmunoTherapy of Cancer. 11 (2023) 5 - p. e006019 , 2023

Link: https://doi.org/10.1136/..

9

The NCI-MATCH trial: lessons for precision oncology:

O'Dwyer, Peter J. ; Gray, Robert J. ; Flaherty, Keith T....
Nature Medicine. 29 (2023) 6 - p. 1349-1357 , 2023

Link: https://doi.org/10.1038/..

10

Limiting mitochondrial plasticity by targeting DRP1 induces..:

Parida, Pravat Kumar ; Marquez-Palencia, Mauricio ; Ghosh, Suvranil...
Nature Cancer. 4 (2023) 6 - p. 893-907 , 2023

Link: https://doi.org/10.1038/..

11

Targeting CXCR4 abrogates resistance to trastuzumab by bloc..:

Liu, Shuying ; Xie, Shelly M. ; Liu, Wenbin...
Breast Cancer Research. 25 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

12

Antiphospholipid syndrome and haemorrhagic complications: A..:

Mayor Barrera, Viviana ; Cajamarca Barón, Jairo Hernán ; Arteaga, Carlos...
Revista Colombiana de Reumatología (English Edition). 30 (2023) 3 - p. 262-269 , 2023

Link: https://doi.org/10.1016/..

13

Phase II Study of Palbociclib (PD-0332991) inCCND1,2, or3Am..:

Clark, Amy S. ; Hong, Fangxin ; Finn, Richard S....
Clinical Cancer Research. 29 (2023) 8 - p. 1477-1483 , 2023

Link: https://doi.org/10.1158/..

14

Metabolic diversity within breast cancer brain-tropic cells..:

Parida, Pravat Kumar ; Marquez-Palencia, Mauricio ; Nair, Vidhya...
Cell Metabolism. 34 (2022) 1 - p. 90-105.e7 , 2022

Link: https://doi.org/10.1016/..

15

Obesity and metabolic syndrome are associated with short-te..:

Bergman, Riley ; Berko, Yvonne A. ; Sanchez, Violeta...
Breast Cancer Research and Treatment. 197 (2022) 2 - p. 307-317 , 2022

Link: https://doi.org/10.1007/..